Finite versus Indefinite Nucleos(t)ide Analogue Therapy of Patients with Chronic Hepatitis B Exhibiting Negative HBsAg Levels after Treatment

AIM: To determine whether a decrease in HBsAg to <0.05 IU/mL could be a criterion for cessation of finite nucleos(t)ide analogue (NUC) therapy in patients with chronic hepatitis B (CHB). METHODS: This was a retrospective analysis of 6715 patients with CHB between January 1998 and May 2016. Patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Haixia, Liu, Yinhui, Zhang, Yufeng, Jie, Yusheng, Wu, Yuankai, Li, Zhanyi, Wei, Xuxia, Li, Xiangyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307367/
https://www.ncbi.nlm.nih.gov/pubmed/35872855
http://dx.doi.org/10.1155/2022/6069781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307367/
https://www.ncbi.nlm.nih.gov/pubmed/35872855
http://dx.doi.org/10.1155/2022/6069781

Ejemplares similares